Sir Patrick Stewart Embraces Medical Cannabis for Hand Mobility in California
Sir Patrick Stewart has revealed he uses a cannabis-based cream in California to improve hand mobility, highlighting the benefits of medical cannabis and the challenges posed by differing international regulations
Key Points
- 1Sir Patrick Stewart uses a cannabis cream in California to improve hand function
- 2He discussed his medical cannabis use during promotion for the film Logan
- 3Stewart highlighted the challenges of accessing medical cannabis when in the UK
- 4California law allows Stewart to legally use cannabis-based treatments
Sir Patrick Stewart, the acclaimed British actor known for his roles as Charles Xavier in the X-Men franchise and Captain Jean-Luc Picard in Star Trek, has publicly shared his use of medical cannabis to manage physical discomfort. While promoting the latest X-Men spin-off, Logan, Stewart, 76, revealed to Esquire magazine that he relies on a cannabis-infused cream to keep his hands functional
The actor's openness about his treatment comes as his on-screen character in Logan grapples with degenerative illness and physical decline, a theme that resonates with Stewart's real-life experience. He explained, "I mean, my main problem is that my hands don't work very well anymore. But thanks to cannabis, they work much better than before. Thanks to California's law, it's just a cream that I apply."
Stewart's candid reflections extend beyond his medical regimen, as he discusses the realities of aging and the challenges it brings. He noted, "I think about aging anyway, I didn't need Logan to think about it. I think about it every day. Not all the time. I don't dwell on it, but I've come to a point where the numbers are against you. Physical things [make me feel old]. You reach an age when you go to the doctor, you tell him your age and he just shrugs and says, 'Oh, is that all?'"
California's progressive cannabis regulations have enabled Stewart to access this form of relief, but the actor faces obstacles when traveling abroad. When asked about his approach in the UK, where medical cannabis access remains restricted, Stewart replied, "I can't answer that question." His response highlights the ongoing discrepancies in global cannabis policy, particularly between the US and the UK
Stewart's public testimony adds to the growing chorus of high-profile figures advocating for the therapeutic use of cannabis. As more celebrities and medical professionals speak out, public perceptions of cannabis are shifting, and regulatory debates are intensifying in many countries. OG Lab notes that Stewart's experience underscores the importance of accessible medical cannabis, especially for aging populations, and highlights the persistent challenges for patients navigating inconsistent international laws
